Paradigm activates first Aus site for osteoarthritis drug trials
Paradigm Biopharmaceuticals (ASX:PAR) has activated its first Australian clinical site as part…
Paradigm Biopharmaceuticals Limited.. (ASX:PAR)
About Paradigm Biopharmaceuticals Limited..
Key Information
PAR In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 03/06/2025 | Phase 3 Knee OA Trial Begins, Site Live, Patient Consented | 145.17KB | 10K |
| 29/05/2025 | Results of Meeting | 97.35KB | 846 |
| 15/05/2025 | Price Sensitive PS PAR Receives US Ethics Approval for Phase 3 | 153.91KB | 20K |
| 29/04/2025 | Notice of General Meeting/Proxy Form | 352.85KB | 27K |
| 29/04/2025 | Price Sensitive PS March 2025 Quarterly Activities Report & Appendix 4C | 1.05MB | 5.3K |
| 18/03/2025 | Paradigm to present at NWR Healthcare Conference | 60.45KB | 23K |
| 14/03/2025 | Application for quotation of securities - PAR | 15.47KB | 3.4K |
| 07/03/2025 | Price Sensitive PS S&P DJI Announces March 2025 Quarterly Rebalance | 174.42KB | 4.4K |